Santhera Pharmaceuticals (SWX:
SANN) was informed by
GIMV NV, Karel Oomstraat 37, BE-2018 Antwerpen, Belgium, that the following funds under its management
- GIMV NV, and
- Adviesbeheer GIMV Life Science NV
together hold 156,192 shares of Santhera Pharmaceuticals Holding AG, representing 5.04% of the voting rights of the shares registered in the Commercial Register.
Carnegie Fund Management Company SA, 5 place de la Gare, LU-1011 Luxembourg, in accordance with the revised disclosure provisions of the SESTA, that its Carnegie Fund II Biotechbridge Sub Fund holds 118,873 shares of Santhera Pharmaceuticals Holding AG, representing 3.84% of the voting rights of the shares registered in the Commercial Register.
* * *
For further information, contact
Thomas Staffelbach, VP Public & Investor Relations
Phone +41 (0)61 906 89 47
